nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Adequate Number of Lymph Nodes Sampled May Determine Appropriate Surgical Modality for Early-Stage NSCLC: A Population-Based Real-World Study
|
Ling, Lixian |
|
|
24 |
3 |
p. e141-e151 |
artikel |
2 |
A Multicenter Retrospective Chart Review of Clinical Outcomes Among Patients With KRAS G12C Mutant Non–Small Cell Lung Cancer
|
Iams, Wade T. |
|
|
24 |
3 |
p. 228-234 |
artikel |
3 |
Anaplastic Lymphoma Kinase (ALK) Positive Neuroendocrine Tumor of Lung With Favorable Response to Alectinib (ALK Inhibitor)
|
Ghimire, Bipin |
|
|
24 |
3 |
p. e113-e116 |
artikel |
4 |
Brief Report: Discordance Between Liquid and Tissue Biopsy-Based Next-Generation Sequencing in Lung Adenocarcinoma at Disease Progression
|
Tran, Misha C. |
|
|
24 |
3 |
p. e117-e121 |
artikel |
5 |
Chemoimmunotherapy vs. Immunotherapy for First Line Treatment of Advanced Non–small Cell Lung Cancer With a PD-L1 Expression ≥50% or ≥90%
|
Shah, Mohsin |
|
|
24 |
3 |
p. 235-243 |
artikel |
6 |
Comparison of Chemotherapy Plus Pembrolizumab vs. Chemotherapy Alone in EGFR-Mutant Non–small-Cell Lung Cancer Patients
|
Chen, Minjiang |
|
|
24 |
3 |
p. 278-286 |
artikel |
7 |
Current and Emerging Treatment Options for Patients With Relapsed Small-cell Lung Carcinoma: A Systematic Literature Review
|
Bernabé-Caro, Reyes |
|
|
24 |
3 |
p. 185-208 |
artikel |
8 |
Editorial Board
|
|
|
|
24 |
3 |
p. A1 |
artikel |
9 |
Liquid Biopsy Screening for Early Detection of Lung Cancer: Current State and Future Directions
|
Zhu, William |
|
|
24 |
3 |
p. 209-217 |
artikel |
10 |
Lung Immune Therapy Evaluation (LITE) Risk, a Novel Prognostic Model for Patients With Advanced Non-Small Cell Lung Cancer Treated With Immune Checkpoint Blockade
|
Navani, Vishal |
|
|
24 |
3 |
p. e152-e159 |
artikel |
11 |
Mocetinostat in Combination With Durvalumab for Patients With Advanced NSCLC: Results From a Phase I/II Study
|
Johnson, Melissa L. |
|
|
24 |
3 |
p. 218-227 |
artikel |
12 |
Prevalence and Predictability of Occult Satellite Nodules in Clinical Stage Ia Non-small Cell Lung Cancer following Lobectomy
|
Kneuertz, Peter J. |
|
|
24 |
3 |
p. e134-e140 |
artikel |
13 |
Prognostic Role of Biologically Active Volume of Disease in Patients With Metastatic Lung Adenocarcinoma
|
Ladbury, Colton |
|
|
24 |
3 |
p. 244-251 |
artikel |
14 |
Rationale and Design of a Single-Arm, Phase 2, Multi-Center Study of Chemo-Immunotherapy Followed by Hypo-Fractionated RT and Maintenance Immunotherapy in Patients With Unresectable Stage III NSCLC: The DEDALUS Trial
|
Filippi, Andrea Riccardo |
|
|
24 |
3 |
p. e122-e125 |
artikel |
15 |
Table of Contents
|
|
|
|
24 |
3 |
p. A3-A6 |
artikel |
16 |
The Association of Improved Overall Survival with NSAIDs in Non–Small Cell Lung Cancer Patients Receiving Immune Checkpoint Inhibitors
|
Sebastian, Nikhil T. |
|
|
24 |
3 |
p. 287-294 |
artikel |
17 |
Treatment Patterns and Outcomes in Resected Early-stage Non-small Cell Lung Cancer: An Analysis of the SEER-Medicare Data
|
West, Howard |
|
|
24 |
3 |
p. 260-268 |
artikel |
18 |
Tumor Volume Is a Better Prognostic Factor than Greatest Tumor Diameter in Operated Stage I-III Non–Small-Cell Lung Cancer
|
Duran, Ayşe Ocak |
|
|
24 |
3 |
p. 252-259 |
artikel |
19 |
Upfront and Repeated Stereotactic Radiosurgery in Patients With Brain Metastases From NSCLC
|
Krämer, Anna S. |
|
|
24 |
3 |
p. 269-277 |
artikel |
20 |
Vascular Invasion Predicts Recurrence in Stage IA2-IB Lung Adenocarcinoma but not Squamous Cell Carcinoma
|
Suaiti, Lubna |
|
|
24 |
3 |
p. e126-e133 |
artikel |